Overview

A Study to Investigate the Potential Interaction Between Telaprevir and Methadone, at Steady-State

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of steady-state (constant concentration of medication in the blood) telaprevir 750 mg every 8 hours on the steady-state pharmacokinetics (how the drug concentrations change over time) of R- and S-methadone.
Phase:
Phase 1
Details
Lead Sponsor:
Tibotec BVBA
Collaborator:
Vertex Pharmaceuticals Incorporated
Treatments:
Methadone